Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul:157:104837.
doi: 10.1016/j.phrs.2020.104837. Epub 2020 Apr 22.

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

Roberto Maggio  1 , Giovanni U Corsini  2
Affiliations
Comment

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

Roberto Maggio et al. Pharmacol Res. 2020 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest We declare no competing interests.

Comment on

References

    1. Lucas J.M., Heinlein C., Kim T., Hernandez S.A., Malik M.S., True L.D., Morrissey C., Corey E., Montgomery B., Mostaghel E., Clegg N., Coleman I., Brown C.M., Schneider E.L., Craik C., Simon J.A., Bedalov A., Nelson P.S. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discov. 2014;4:1310–1325. https://www.ncbi.nlm.nih.gov/pubmed/25122198/ - PMC - PubMed
    1. Böttcher E., Matrosovich T., Beyerle M., Klenk H.D., Garten W., Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 2006;80:9896–9898. https://www.ncbi.nlm.nih.gov/pubmed/16973594/ - PMC - PubMed
    1. Iwata-Yoshikawa N., Okamura T., Shimizu Y., Hasegawa H., Takeda M., Nagata N. TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. J. Virol. 2019;93(6):e01815–01818. https://www.ncbi.nlm.nih.gov/pubmed/30626688/ - PMC - PubMed
    1. Hoffmann M., Kleine-Weber H., Schroeder S., Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., Müller M.A., Drosten C., Pöhlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 https://www.ncbi.nlm.nih.gov/pubmed/32142651/ pii: S0092-8674(20)30229-4. - PMC - PubMed
    1. Kawase M., Shirato K., van der Hoek L., Taguchi F., Matsuyama S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J. Virol. 2012;86:6537–6545. https://www.ncbi.nlm.nih.gov/pubmed/224962166/ - PMC - PubMed